Cargando…

Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial

OBJECTIVE: Vitiligo is a common, autoimmune disease that results in the destruction of the melanocytes and manifests as depigmented macules on various areas of the skin. Numerous treatment options have been proposed for vitiligo. The purpose of this study was to compare the efficacy of microneedling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iraji, Fariba, Asilian, Ali, Talebzadeh, Zahra, Saber, Mina, Mokhtari, Fatemeh, Siadat, Amirhossein, Hosseini, Seyed Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651420/ https://www.ncbi.nlm.nih.gov/pubmed/34887918 http://dx.doi.org/10.1155/2021/5652140

Ejemplares similares

Successful Treatment of Cutaneous Lesions of Dermatomyositis with Topical Pimecrolimus
por: Kim, Ji Eun, et al.
Publicado: (2011)

Successful Treatment of Localized Pemphigus Foliaceus with Topical Pimecrolimus
por: Tyros, G., et al.
Publicado: (2013)

A Pilot Study of 1% Pimecrolimus Cream for the Treatment of Childhood Segmental Vitiligo
por: Shim, Woo-Haing, et al.
Publicado: (2013)

Topical Pimecrolimus as a New Optional Treatment in Cutaneous Sarcoidosis of Lichenoid Type
por: Tammaro, Antonella, et al.
Publicado: (2014)

Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study
por: Kuiper, Josephina G., et al.
Publicado: (2018)

Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood
por: Boms, Stefanie, et al.
Publicado: (2004)

Pimecrolimus cream in the management of patients with atopic eczema
por: Spergel, Jonathan M
Publicado: (2009)

Pimecrolimus increases the melanogenesis and migration of melanocytes in vitro
por: Xu, Ping, et al.
Publicado: (2017)

Health Plan Budget Impact Analysis for Pimecrolimus
por: Chang, Jane, et al.
Publicado: (2005)

Treatment of atopic dermatitis with pimecrolimus – impact on quality of life
por: Lee, Hae-Hyuk, et al.
Publicado: (2007)

Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
por: Chu, Chia-Yu, et al.
Publicado: (2023)

Successful management of Zoons balanitis with the combination of pimecrolimus and excimer laser
por: Udare, Satish, et al.
Publicado: (2022)

Formulary Review of Therapeutic Alternatives for Atopic Dermatitis: Focus on Pimecrolimus
por: Weinberg, Jeffery M.
Publicado: (2005)

Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis
por: Yin, Zhiqiang, et al.
Publicado: (2011)

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
por: Luger, Thomas, et al.
Publicado: (2015)

Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?
por: Beriat, Güçlü Kaan, et al.
Publicado: (2012)

Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis
por: Huang, Chunyun, et al.
Publicado: (2014)

The Effect of Pimecrolimus Cream 1% Compared with Triamcinolone Acetonide Paste in Treatment of Atrophic-Erosive Oral Lichen Planus
por: Pakfetrat, Atessa, et al.
Publicado: (2015)

Topical pimecrolimus inhibits high-dose UVB irradiation-induced epidermal Langerhans cell migration, via regulation of TNF-α and E-cadherin
por: Yin, ZhiQiang, et al.
Publicado: (2014)

Retraction: Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis
Publicado: (2014)

Reiter's disease: Circinate balanitis as alone preceding presentation - Successfully treated with pimecrolimus 1% cream
por: Kumar, Sumir, et al.
Publicado: (2015)

Localized Follicular Mucinosis in a Child Treated Successfully with Pimecrolimus and Targeted Phototherapy
por: Mutalik, Sharad, et al.
Publicado: (2022)

Treatment of Facial Seborrheic Dermatitis with Pimecrolimus Cream 1%: An Open-Label Clinical Study in Korean Patients
por: Kim, Byung-Soo, et al.
Publicado: (2007)

A Comparative Study of Microneedling Combined with Topical 5-Fluorouracil versus Microneedling Alone in Treatment of Localized Stable Vitiligo
por: Chhabra, Shaiphali, et al.
Publicado: (2021)

Comparative Evaluation of Pimecrolimus Cream 1% and Triamcinolone Aceonide Paste in Treatment of Atrophic–Erosive Oral Lichen Planus
por: Bajoria, Atul Anand, et al.
Publicado: (2023)

Relative efficacy of pimecrolimus cream and triamcinolone acetonide paste in the treatment of symptomatic oral lichen planus
por: Arunkumar, Shantala, et al.
Publicado: (2015)

Experts’ Consensus on the Use of Pimecrolimus in Atopic Dermatitis in China: A TCS-Sparing Practical Approach
por: Zhao, Zuotao, et al.
Publicado: (2022)

PandT Committees - Black Boxes Versus AMCP Format, and What Is the True Cost and Value of Pimecrolimus
por: Curtiss, Frederic R.
Publicado: (2005)

A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)
por: Castellsague, Jordi, et al.
Publicado: (2018)

Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life
por: Murashkin, Nikolay N., et al.
Publicado: (2023)

Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro
por: Heneberg, Petr, et al.
Publicado: (2015)

Effects of Mycophenolate Mofetil, Methotrexate and Pimecrolimus on cdk4 and p16 in Erosive Oral Lichen Planus
por: Goel, Sinny, et al.
Publicado: (2021)

The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials
por: Alsmeirat, Odeh, et al.
Publicado: (2022)

Efficacy of adding topical simvastatin to topical calcipotriol on improvement of cutaneous plaque psoriasis
por: Iraji, Fariba, et al.
Publicado: (2014)

Administrative Claims Analysis of Utilization and Costs of Care in Health Plan Members With Atopic Dermatitis Who Had Prior Use of a Topical Corticosteroid and Who Initiate Therapy With Pimecrolimus or Tacrolimus
por: Delea, Thomas E., et al.
Publicado: (2007)

Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
por: Shin, Nari, et al.
Publicado: (2021)

Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)
por: Arana, Alejandro, et al.
Publicado: (2021)

Safety and efficacy of pimecrolimus versus vehicle for the treatment of atopic dermatitis in adults and paediatric population: a systematic review and meta-analysis
por: Akhtar, Sareema E., et al.
Publicado: (2023)

Topical nicotinamide in combination with calcipotriol for the treatment of mild to moderate psoriasis: A double-blind, randomized, comparative study
por: Siadat, Amir Hossein, et al.
Publicado: (2013)

Repigmentation of Hypopigmented Scars Using Combination of Fractionated Carbon Dioxide Laser with Topical Latanoprost Vs. Fractionated Carbon Dioxide Laser Alone
por: Siadat, Amir Hossein, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nuausfshqler60651iqv5jl3iu